Trial Profile
Effects of Intravitreal Bevacizumab (Avastin) therapy on visual acuity in patients with Proliferative Diabetic Retinopathy.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 13 Sep 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Diabetic retinopathy
- Focus Therapeutic Use
- 21 Sep 2011 New trial record